Report Detail
Global Pirfenidone Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4753103 |
- 05 October, 2026 |
- Global |
- 103 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Pirfenidone Drugs market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Pirfenidone is an antifibrotic drug used primarily in the treatment of idiopathic pulmonary fibrosis(IPF),a progressive and debilitating lung disease characterized by scarring of lung tissue.It works by inhibiting the synthesis of transforming growth factor-beta(TGF-β),andpirfenidone exerts anti-inflammatory effects by suppressing the release of pro-inflammatory mediators and inhibiting the expression of genes associated with inflammation.
This report is a detailed and comprehensive analysis for global Pirfenidone Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pirfenidone Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Pirfenidone Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Pirfenidone Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Pirfenidone Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pirfenidone Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pirfenidone Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Accord Healthcare, Amneal Pharmaceuticals, Sandoz, ScieGen Pharmaceuticals, Gyre Pharmaceuticals, Apotex, Teva, Kawin, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pirfenidone Drugs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Capsules
Tablets
Market segment by Application
Hospital and Clinic
Retail Pharmacies
Other
Major players covered
Roche
Accord Healthcare
Amneal Pharmaceuticals
Sandoz
ScieGen Pharmaceuticals
Gyre Pharmaceuticals
Apotex
Teva
Kawin
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pirfenidone Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pirfenidone Drugs, with price, sales quantity, revenue, and global market share of Pirfenidone Drugs from 2021 to 2026.
Chapter 3, the Pirfenidone Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pirfenidone Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Pirfenidone Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pirfenidone Drugs.
Chapter 14 and 15, to describe Pirfenidone Drugs sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Pirfenidone Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Capsules
- 1.3.3 Tablets
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Pirfenidone Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital and Clinic
- 1.4.3 Retail Pharmacies
- 1.4.4 Other
- 1.5 Global Pirfenidone Drugs Market Size & Forecast
- 1.5.1 Global Pirfenidone Drugs Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Pirfenidone Drugs Sales Quantity (2021-2032)
- 1.5.3 Global Pirfenidone Drugs Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Roche
- 2.1.1 Roche Details
- 2.1.2 Roche Major Business
- 2.1.3 Roche Pirfenidone Drugs Product and Services
- 2.1.4 Roche Pirfenidone Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Roche Recent Developments/Updates
- 2.2 Accord Healthcare
- 2.2.1 Accord Healthcare Details
- 2.2.2 Accord Healthcare Major Business
- 2.2.3 Accord Healthcare Pirfenidone Drugs Product and Services
- 2.2.4 Accord Healthcare Pirfenidone Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Accord Healthcare Recent Developments/Updates
- 2.3 Amneal Pharmaceuticals
- 2.3.1 Amneal Pharmaceuticals Details
- 2.3.2 Amneal Pharmaceuticals Major Business
- 2.3.3 Amneal Pharmaceuticals Pirfenidone Drugs Product and Services
- 2.3.4 Amneal Pharmaceuticals Pirfenidone Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Amneal Pharmaceuticals Recent Developments/Updates
- 2.4 Sandoz
- 2.4.1 Sandoz Details
- 2.4.2 Sandoz Major Business
- 2.4.3 Sandoz Pirfenidone Drugs Product and Services
- 2.4.4 Sandoz Pirfenidone Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Sandoz Recent Developments/Updates
- 2.5 ScieGen Pharmaceuticals
- 2.5.1 ScieGen Pharmaceuticals Details
- 2.5.2 ScieGen Pharmaceuticals Major Business
- 2.5.3 ScieGen Pharmaceuticals Pirfenidone Drugs Product and Services
- 2.5.4 ScieGen Pharmaceuticals Pirfenidone Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 ScieGen Pharmaceuticals Recent Developments/Updates
- 2.6 Gyre Pharmaceuticals
- 2.6.1 Gyre Pharmaceuticals Details
- 2.6.2 Gyre Pharmaceuticals Major Business
- 2.6.3 Gyre Pharmaceuticals Pirfenidone Drugs Product and Services
- 2.6.4 Gyre Pharmaceuticals Pirfenidone Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Gyre Pharmaceuticals Recent Developments/Updates
- 2.7 Apotex
- 2.7.1 Apotex Details
- 2.7.2 Apotex Major Business
- 2.7.3 Apotex Pirfenidone Drugs Product and Services
- 2.7.4 Apotex Pirfenidone Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Apotex Recent Developments/Updates
- 2.8 Teva
- 2.8.1 Teva Details
- 2.8.2 Teva Major Business
- 2.8.3 Teva Pirfenidone Drugs Product and Services
- 2.8.4 Teva Pirfenidone Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Teva Recent Developments/Updates
- 2.9 Kawin
- 2.9.1 Kawin Details
- 2.9.2 Kawin Major Business
- 2.9.3 Kawin Pirfenidone Drugs Product and Services
- 2.9.4 Kawin Pirfenidone Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Kawin Recent Developments/Updates
3 Competitive Environment: Pirfenidone Drugs by Manufacturer
- 3.1 Global Pirfenidone Drugs Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Pirfenidone Drugs Revenue by Manufacturer (2021-2026)
- 3.3 Global Pirfenidone Drugs Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Pirfenidone Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Pirfenidone Drugs Manufacturer Market Share in 2025
- 3.4.3 Top 6 Pirfenidone Drugs Manufacturer Market Share in 2025
- 3.5 Pirfenidone Drugs Market: Overall Company Footprint Analysis
- 3.5.1 Pirfenidone Drugs Market: Region Footprint
- 3.5.2 Pirfenidone Drugs Market: Company Product Type Footprint
- 3.5.3 Pirfenidone Drugs Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Pirfenidone Drugs Market Size by Region
- 4.1.1 Global Pirfenidone Drugs Sales Quantity by Region (2021-2032)
- 4.1.2 Global Pirfenidone Drugs Consumption Value by Region (2021-2032)
- 4.1.3 Global Pirfenidone Drugs Average Price by Region (2021-2032)
- 4.2 North America Pirfenidone Drugs Consumption Value (2021-2032)
- 4.3 Europe Pirfenidone Drugs Consumption Value (2021-2032)
- 4.4 Asia-Pacific Pirfenidone Drugs Consumption Value (2021-2032)
- 4.5 South America Pirfenidone Drugs Consumption Value (2021-2032)
- 4.6 Middle East & Africa Pirfenidone Drugs Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Pirfenidone Drugs Sales Quantity by Type (2021-2032)
- 5.2 Global Pirfenidone Drugs Consumption Value by Type (2021-2032)
- 5.3 Global Pirfenidone Drugs Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Pirfenidone Drugs Sales Quantity by Application (2021-2032)
- 6.2 Global Pirfenidone Drugs Consumption Value by Application (2021-2032)
- 6.3 Global Pirfenidone Drugs Average Price by Application (2021-2032)
7 North America
- 7.1 North America Pirfenidone Drugs Sales Quantity by Type (2021-2032)
- 7.2 North America Pirfenidone Drugs Sales Quantity by Application (2021-2032)
- 7.3 North America Pirfenidone Drugs Market Size by Country
- 7.3.1 North America Pirfenidone Drugs Sales Quantity by Country (2021-2032)
- 7.3.2 North America Pirfenidone Drugs Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Pirfenidone Drugs Sales Quantity by Type (2021-2032)
- 8.2 Europe Pirfenidone Drugs Sales Quantity by Application (2021-2032)
- 8.3 Europe Pirfenidone Drugs Market Size by Country
- 8.3.1 Europe Pirfenidone Drugs Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Pirfenidone Drugs Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Pirfenidone Drugs Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Pirfenidone Drugs Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Pirfenidone Drugs Market Size by Region
- 9.3.1 Asia-Pacific Pirfenidone Drugs Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Pirfenidone Drugs Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Pirfenidone Drugs Sales Quantity by Type (2021-2032)
- 10.2 South America Pirfenidone Drugs Sales Quantity by Application (2021-2032)
- 10.3 South America Pirfenidone Drugs Market Size by Country
- 10.3.1 South America Pirfenidone Drugs Sales Quantity by Country (2021-2032)
- 10.3.2 South America Pirfenidone Drugs Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Pirfenidone Drugs Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Pirfenidone Drugs Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Pirfenidone Drugs Market Size by Country
- 11.3.1 Middle East & Africa Pirfenidone Drugs Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Pirfenidone Drugs Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Pirfenidone Drugs Market Drivers
- 12.2 Pirfenidone Drugs Market Restraints
- 12.3 Pirfenidone Drugs Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Pirfenidone Drugs and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Pirfenidone Drugs
- 13.3 Pirfenidone Drugs Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Pirfenidone Drugs Typical Distributors
- 14.3 Pirfenidone Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Pirfenidone Drugs. Industry analysis & Market Report on Pirfenidone Drugs is a syndicated market report, published as Global Pirfenidone Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Pirfenidone Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
